Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy
Authors
Keywords
PFKFB3, Ki67, Lung adenocarcinoma, A549, Prognosis, Therapy
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 445, Issue 1-2, Pages 123-134
Publisher
Springer Nature
Online
2018-01-11
DOI
10.1007/s11010-017-3258-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma
- (2017) Hui-Min Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Gene aberrations for precision medicine against lung adenocarcinoma
- (2016) Motonobu Saito et al. CANCER SCIENCE
- PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer
- (2016) Wei Zhu et al. PLoS One
- Expression and Prognostic Implications of FOXO3a and Ki67 in Lung Adenocarcinomas
- (2015) Hong-Bin Liu et al. Asian Pacific Journal of Cancer Prevention
- Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting
- (2015) Xin Ge et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- How do K-RAS-activated cells evade cellular defense mechanisms?
- (2015) Y-S Lee et al. ONCOGENE
- Targeting ECM Disrupts Cancer Progression
- (2015) Freja A. Venning et al. Frontiers in Oncology
- Endothelial PFKFB3 Plays a Critical Role in Angiogenesis
- (2014) Yiming Xu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Non–Small Cell Lung Cancer and Precision Medicine
- (2014) Boris Pasche et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells
- (2014) Oleksandr H Minchenko WORLD JOURNAL OF GASTROENTEROLOGY
- 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27
- (2014) A Yalcin et al. Cell Death & Disease
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- RETfusion gene: Translation to personalized lung cancer therapy
- (2013) Takashi Kohno et al. CANCER SCIENCE
- Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
- (2013) Katrien De Bock et al. CELL
- Partial and Transient Reduction of Glycolysis by PFKFB3 Blockade Reduces Pathological Angiogenesis
- (2013) Sandra Schoors et al. Cell Metabolism
- Vacuolar protein sorting 4B, an ATPase protein positively regulates the progression of NSCLC via promoting cell division
- (2013) Yifei Liu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Targeting 6-Phosphofructo-2-Kinase (PFKFB3) as a Therapeutic Strategy against Cancer
- (2013) B. F. Clem et al. MOLECULAR CANCER THERAPEUTICS
- Role of Centromere Protein H and Ki67 in Relapse-free Survival of Patients after Primary Surgery for Hypopharyngeal Cancer
- (2012) Jun-Xi Wang et al. Asian Pacific Journal of Cancer Prevention
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nuclear Targeting of 6-Phosphofructo-2-kinase (PFKFB3) Increases Proliferation via Cyclin-dependent Kinases
- (2009) Abdullah Yalcin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
- (2008) B. Clem et al. MOLECULAR CANCER THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started